Navigation Links
Newborns Affected By Antidepressant Intake Of Mothers

Researchers have advised expectant mothers to reduce the intake of anti-depressant drugs, as it is likely to affect the new born with withdrawal symptoms. // The newborn babies of such mothers display symptoms like disturbed sleep, gastrointestinal problems, high-pitched crying, and tremors within 48 hours after birth.

These symptoms are higher in the case of babies of women who had taken higher doses of the medicines. The risk factors were lesser in the case of women who consumed less than 20 milligrams of GlaxoSmithKline’s paroxetine hydrochloride, and higher in the case of dosages of more than 27 milligrams. As many as 30% of the babies who had received exposure to selective serotonin reuptake inhibitors (SSRIs) displayed withdrawal symptoms, and in 13% of the cases the symptoms were seen to be very severe.

The Children's Medical Center of Israel’s Dr. Rachel Levinson-Castiel conducted the research study. The effects of the drugs on children in the long term still remain unknown, even though seizures were reported in a few cases. Other symptoms like jitteriness, low blood sugar, feeding difficulties, and lack of oxygen have also been reported. The children also have to face the consequences of maternal depression during the period of pregnancy. The most frequently used antidepressants are Paxil, Prozac, Celexa, and Zoloft.
'"/>




Page: 1

Related medicine news :

1. Screening Newborns Questioned
2. Cooling Can Reduce The Risk Of Brain Damage In Oxygen Deprived Newborns
3. Newborns Know how to make eye contact
4. New Portable Helmet Scanner To Examine Newborns
5. Use Of Alcohol During Pregnancy Affects Newborns
6. Exposure To Solvents May Harm Pregnant Women And Newborns
7. Pre-gestational Diabetes in Mothers enhances the Risk of Hypocalcaemia in Newborns
8. Newborns Cerebral Palsy Risk Increased By Alzheimers Gene
9. Newborns With Respiratory Distress Potentially Have Rare Genetic Disease
10. Harmful Effects Of Glucocorticoids On Newborns Owing To Prenatal Exposure
11. PFOA and PFOS Detected in Newborns
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Flottman ... and outserts. As a means of expanding capabilities Flottman has added a ... to individually code professional inserts (PIs) and patient package inserts (PPIs) that will ...
(Date:12/9/2016)... , ... December 09, 2016 , ... An inventor from ... to safely ride all types of amusement park rides. , The patent-pending SAFETY STRAP ... is easy to use and could be set up in a matter of minutes, ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec 9, 2016 Research ... Screening Market - Forecast to 2021" report to their ... ... of open innovative models in the pharmaceutical and biotechnology industry ... and rising government funding. Emerging markets and growing research activities ...
(Date:12/9/2016)...  RxWiki Inc., a digital health company that powers ... thousands of pharmacies through its Digital Pharmacist SaaS platform, ... "50 on Fire" Award in the Health and Life ... the award as one of Austin,s fastest growing companies," ... RxWiki. "Our platform gives independent retail pharmacies the digital ...
(Date:12/9/2016)... , Dec. 9, 2016  Forge Therapeutics, ... AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) ... ,LpxC, for the treatment of bacterial infections including ... been recognized as an attractive antibacterial target for ... lack of suitable chemical starting points has hampered ...
Breaking Medicine Technology: